Characterizing technical success and clinical outcomes in patients with pulmonary embolism treated with ultrasound-assisted catheter-directed thrombolysis (USAT): a retrospective, single-center cohort study
- PMID: 40387890
- DOI: 10.1007/s00392-025-02643-2
Characterizing technical success and clinical outcomes in patients with pulmonary embolism treated with ultrasound-assisted catheter-directed thrombolysis (USAT): a retrospective, single-center cohort study
Abstract
Background: Ultrasound-assisted catheter-directed thrombolysis (USAT) is a treatment option for patients with intermediate-high- or high-risk pulmonary embolism (PE). This study aimed to describe the use of USAT and its clinical outcomes.
Methods: In this single-center retrospective cohort study, all USAT procedures performed between May 2019 and June 2022 were included. Data were collected from electronic health records. The primary outcome was reduction in right vs. left ventricular diameter (RV/LV ratio). Secondary outcomes were in-hospital mortality and bleeding.
Results: A total of 107 patients underwent USAT for PE. The median age was 64 (IQR 53-75) years and 59% were male. Technical success of USAT was achieved in 105 (98%) cases. In 32 cases data on RV/LV ratio changes were available. RV/LV ratio decreased by 0.29 ± 0.19 from 1.19 (1.02-1.35) to 0.89 (0.78-1.00). 12 (11%) patients had a fatal outcome. Bleeding complications were observed in 28 (26%) patients, including 14 (13%) major bleedings and 0 (0%) fatal. Both, death and bleeding rates were significantly higher in high-risk patients.
Conclusion: We observed a high technical success of USAT in patients with intermediate-high- and high-risk pulmonary embolism, along with a significant early reduction of RV/LV ratio following treatment.
Keywords: Catheter-directed thrombolysis; Pulmonary embolism; Right ventricular dysfunction; Ultrasound-assisted catheter-directed thrombolysis.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: Marius Wessinger reports no conflict of interest. Christoph B. Olivier reports research support from Bundesministerium für Bildung und Forschung, Deutsche Forschungsgemeinschaft, Deutsche Herzstiftung, Freiburg University, Else Kröner-Fresenius Stiftung, and Haemonetics; Honoraria: Bayer Vital GmbH, BMS, Böhringer Ingelheim, Daiichi Sankyo, Ferrer, Idorsia, and Janssen; none of them related to this research.
Similar articles
-
Ultrasound-accelerated thrombolysis (USAT) versus standard catheter-directed thrombolysis (CDT) for treatment of pulmonary embolism: A retrospective analysis.Vasc Med. 2019 Jun;24(3):234-240. doi: 10.1177/1358863X19838350. Epub 2019 Mar 27. Vasc Med. 2019. PMID: 30915912
-
Comparison of ultrasound-assisted thrombolysis and mechanical thrombectomy in intermediate-high-risk pulmonary embolism.Vasa. 2025 Jan 30. doi: 10.1024/0301-1526/a001180. Online ahead of print. Vasa. 2025. PMID: 39882734
-
Ultrasound-Assisted Catheter-Directed Thrombolysis in High-Risk and Intermediate-High-Risk Pulmonary Embolism: A Meta-Analysis.Curr Vasc Pharmacol. 2018 Jan 26;16(2):179-189. doi: 10.2174/1570161115666170404122535. Curr Vasc Pharmacol. 2018. PMID: 28393706 Review.
-
Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.Circulation. 2014 Jan 28;129(4):479-86. doi: 10.1161/CIRCULATIONAHA.113.005544. Epub 2013 Nov 13. Circulation. 2014. PMID: 24226805 Clinical Trial.
-
Clinical efficacy and safety of ultrasound-assisted thrombolysis vs. standard catheter-directed thrombolysis in patients with acute pulmonary embolism: A study level meta-analysis of clinical trials.Front Cardiovasc Med. 2022 Oct 5;9:967786. doi: 10.3389/fcvm.2022.967786. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36277787 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources